DE2415353C2 - - Google Patents
Info
- Publication number
- DE2415353C2 DE2415353C2 DE19742415353 DE2415353A DE2415353C2 DE 2415353 C2 DE2415353 C2 DE 2415353C2 DE 19742415353 DE19742415353 DE 19742415353 DE 2415353 A DE2415353 A DE 2415353A DE 2415353 C2 DE2415353 C2 DE 2415353C2
- Authority
- DE
- Germany
- Prior art keywords
- viruses
- herpes simplex
- temperature
- simplex type
- herpes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 claims description 27
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 19
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 18
- 229960005486 vaccine Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 230000001717 pathogenic effect Effects 0.000 claims description 10
- 238000004448 titration Methods 0.000 claims description 9
- 210000003292 kidney cell Anatomy 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 5
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000008351 acetate buffer Substances 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 description 36
- 238000002255 vaccination Methods 0.000 description 22
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 19
- 208000024891 symptom Diseases 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 239000000725 suspension Substances 0.000 description 9
- 238000011534 incubation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000005084 renal tissue Anatomy 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 208000007542 Paresis Diseases 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000007918 intramuscular administration Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 241001529453 unidentified herpesvirus Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000548 hind-foot Anatomy 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 208000035415 Reinfection Diseases 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- -1 nitrite ions Chemical class 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1530773A GB1390467A (en) | 1973-03-30 | 1973-03-30 | Vaccination method using temperature sensitive virus mutants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2415353A1 DE2415353A1 (de) | 1974-10-03 |
| DE2415353C2 true DE2415353C2 (en, 2012) | 1987-10-01 |
Family
ID=10056766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2415353A Granted DE2415353A1 (de) | 1973-03-30 | 1974-03-29 | Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3897549A (en, 2012) |
| JP (1) | JPS6035327B2 (en, 2012) |
| BE (1) | BE812816A (en, 2012) |
| CA (1) | CA1021261A (en, 2012) |
| DE (1) | DE2415353A1 (en, 2012) |
| FR (1) | FR2223004B1 (en, 2012) |
| GB (1) | GB1390467A (en, 2012) |
| HU (1) | HU169253B (en, 2012) |
| NL (1) | NL7404054A (en, 2012) |
| ZA (1) | ZA741441B (en, 2012) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374127A (en) * | 1977-09-19 | 1983-02-15 | Merck & Co., Inc. | Herpes sub unit vaccine |
| US4452734A (en) * | 1980-02-11 | 1984-06-05 | Merck & Co., Inc. | Herpes subunit vaccine |
| US4554159A (en) * | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
| US4714678A (en) * | 1982-10-13 | 1987-12-22 | Smithkline-Rit | Temperature sensitive strain of bovine viral diarrhoea virus |
| US4618493A (en) * | 1982-10-13 | 1986-10-21 | Smithkline-Rit | Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them |
| RU2251434C1 (ru) * | 2004-03-19 | 2005-05-10 | Государственное образовательное учреждение "Красноярская государственная медицинская академия Министерства здравоохранения РФ" | Способ вакцинации против краснухи на крайнем севере |
| RU2271830C1 (ru) * | 2004-07-12 | 2006-03-20 | ГУ Научно-исследовательский институт медицинских проблем Севера СО РАМН | Способ вакцинопрофилактики краснухи на крайнем севере |
| RU2303459C1 (ru) * | 2005-12-05 | 2007-07-27 | ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) | Способ вакцинации детей против краснухи на крайнем севере |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4848621A (en, 2012) * | 1971-10-20 | 1973-07-10 | ||
| DE2215728C3 (de) * | 1972-03-30 | 1979-02-15 | Stickl, Helmut, Prof. Dr.Med., 8033 Krailling | Arzneimittel zur Behandlung von Herpes simplex |
-
1973
- 1973-03-30 GB GB1530773A patent/GB1390467A/en not_active Expired
-
1974
- 1974-03-05 ZA ZA00741441A patent/ZA741441B/xx unknown
- 1974-03-07 US US44885074 patent/US3897549A/en not_active Expired - Lifetime
- 1974-03-25 FR FR7410112A patent/FR2223004B1/fr not_active Expired
- 1974-03-26 BE BE142433A patent/BE812816A/xx not_active IP Right Cessation
- 1974-03-26 NL NL7404054A patent/NL7404054A/xx unknown
- 1974-03-29 JP JP49036567A patent/JPS6035327B2/ja not_active Expired
- 1974-03-29 CA CA196,323A patent/CA1021261A/en not_active Expired
- 1974-03-29 HU HURE000548 patent/HU169253B/hu unknown
- 1974-03-29 DE DE2415353A patent/DE2415353A1/de active Granted
Non-Patent Citations (8)
| Title |
|---|
| Experimental Neurology, Vol. 9, 85-95 (1964) * |
| J. Hyg. Camb. 70, 1972, 229-234 * |
| J. of Gen. Virology, Vol. 2, 357-364 (1968) * |
| JAWETZ, E., MELNICK, J.L., ADELBERG, E.A., Me- dizinische Microbiologie, 4. Aufl., 1977, 627-633 * |
| Microbiology, 1. Aufl., 1967, 242-244 * |
| Perspectives in Virology VIII, 1973, 129-169 * |
| The Journal of Immunology, Vol. 98, No. 5, 941-947 (1967) * |
| The Journal of Infectious Diseases 126, 1972, 170-178 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA741441B (en) | 1975-02-26 |
| BE812816A (fr) | 1974-09-26 |
| JPS5029736A (en, 2012) | 1975-03-25 |
| DE2415353A1 (de) | 1974-10-03 |
| FR2223004B1 (en, 2012) | 1978-01-06 |
| CA1021261A (en) | 1977-11-22 |
| HU169253B (en, 2012) | 1976-10-28 |
| JPS6035327B2 (ja) | 1985-08-14 |
| FR2223004A1 (en, 2012) | 1974-10-25 |
| NL7404054A (en, 2012) | 1974-10-02 |
| GB1390467A (en) | 1975-04-16 |
| AU6708674A (en) | 1975-09-25 |
| US3897549A (en) | 1975-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2708668A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
| DE2817891A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
| DE1617940C2 (de) | Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes | |
| DE2713371C2 (en, 2012) | ||
| DE2463143C2 (de) | Polyvalente Rindervirus-Lebendimpfstoffe | |
| DE2415353C2 (en, 2012) | ||
| DE2362067C2 (de) | Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen | |
| DD232822A5 (de) | Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit | |
| DE2616407A1 (de) | Tollwut-vaccine und verfahren zu ihrer herstellung | |
| DE2803240A1 (de) | Tollwut-impfstoff | |
| DE2553998C2 (de) | Mumpsvaccin und Verfahren zu seiner Herstellung | |
| DE2655691C2 (de) | Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine | |
| DE2445819A1 (de) | Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE69328341T2 (de) | Impfstoff gegen infektiöse Bursal-Krankheit | |
| DE2425997A1 (de) | Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin | |
| DE2212277C3 (de) | Verfahren zur Herstellung einer Totvaccine gegen infektiöse atrophische Rhinitis der Schweine | |
| DE2456636A1 (de) | Influenza-vakzine und verfahren zu ihrer herstellung | |
| DE2058645C2 (de) | Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs | |
| DE2200376A1 (de) | Vaccine gegen Streptococcus equi. und Verfahren zu deren Herstellung | |
| DE2225548C3 (de) | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis | |
| DE3009064C2 (de) | Verfahren zur Herstellung eines Tollwutimpfstoffes | |
| DE2045160A1 (de) | Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Huhner | |
| WO1989005154A1 (en) | Process for producing an avirulent cold blood virus | |
| DE2805029C2 (de) | Impfstoff gegen virale hämorrhagische Sepsis von Forellen sowie Verfahren zu dessen Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OGA | New person/name/address of the applicant | ||
| 8126 | Change of the secondary classification | ||
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |